C. L. Viswanathan

436 total citations
19 papers, 380 citations indexed

About

C. L. Viswanathan is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, C. L. Viswanathan has authored 19 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Organic Chemistry, 7 papers in Molecular Biology and 4 papers in Infectious Diseases. Recurrent topics in C. L. Viswanathan's work include Synthesis and biological activity (6 papers), Synthesis and Characterization of Heterocyclic Compounds (3 papers) and Neuroscience and Neuropharmacology Research (3 papers). C. L. Viswanathan is often cited by papers focused on Synthesis and biological activity (6 papers), Synthesis and Characterization of Heterocyclic Compounds (3 papers) and Neuroscience and Neuropharmacology Research (3 papers). C. L. Viswanathan collaborates with scholars based in India and Germany. C. L. Viswanathan's co-authors include Firoz A. Kalam Khan, Aarti Juvekar, Vivek Dhawan, Dibyendu Bhattacharyya, Mangal S. Nagarsenker, Alfred Fahr and Frank Steiniger and has published in prestigious journals such as European Journal of Medicinal Chemistry, Carbohydrate Research and Bioorganic & Medicinal Chemistry.

In The Last Decade

C. L. Viswanathan

17 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. L. Viswanathan India 10 265 125 31 27 26 19 380
Thomas D. Avery Australia 14 338 1.3× 111 0.9× 43 1.4× 13 0.5× 22 0.8× 28 523
Karla C. Pais Brazil 11 274 1.0× 157 1.3× 25 0.8× 17 0.6× 45 1.7× 14 415
Wei-Chieh Cheng United States 8 180 0.7× 113 0.9× 36 1.2× 13 0.5× 58 2.2× 10 334
Parameshwar Makam India 12 459 1.7× 126 1.0× 56 1.8× 23 0.9× 36 1.4× 21 577
Jozef Csöllei Czechia 11 275 1.0× 163 1.3× 43 1.4× 12 0.4× 23 0.9× 60 410
Kishore P. Bhusari India 10 361 1.4× 92 0.7× 53 1.7× 18 0.7× 19 0.7× 25 526
Silvia E. Ası́s Argentina 10 309 1.2× 117 0.9× 16 0.5× 16 0.6× 11 0.4× 27 369
Garima Verma India 4 310 1.2× 125 1.0× 37 1.2× 14 0.5× 15 0.6× 7 399
Lucie Brulíková Czechia 11 233 0.9× 166 1.3× 13 0.4× 27 1.0× 49 1.9× 26 352
M. B. Sridhara India 11 312 1.2× 140 1.1× 29 0.9× 21 0.8× 21 0.8× 20 417

Countries citing papers authored by C. L. Viswanathan

Since Specialization
Citations

This map shows the geographic impact of C. L. Viswanathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. L. Viswanathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. L. Viswanathan more than expected).

Fields of papers citing papers by C. L. Viswanathan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. L. Viswanathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. L. Viswanathan. The network helps show where C. L. Viswanathan may publish in the future.

Co-authorship network of co-authors of C. L. Viswanathan

This figure shows the co-authorship network connecting the top 25 collaborators of C. L. Viswanathan. A scholar is included among the top collaborators of C. L. Viswanathan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. L. Viswanathan. C. L. Viswanathan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Nagarsenker, Mangal S., Vivek Dhawan, Dibyendu Bhattacharyya, et al.. (2015). Cholesterol anchored arabinogalactan for asialoglycoprotein receptor targeting: synthesis, characterization, and proof of concept of hepatospecific delivery. Carbohydrate Research. 408. 33–43. 29 indexed citations
2.
Viswanathan, C. L., et al.. (2014). SYNTHESIS, CHARACTERIZATION AND EVALUATION OF NOVEL 6- SUBSTITUTED BENZIMIDAZOLE-2-CARBAMATES AS POTENTIAL ANTIMICROBIAL AGENTS. International Journal of Pharmacy and Pharmaceutical Sciences. 6(9). 372–375. 3 indexed citations
3.
Viswanathan, C. L., et al.. (2014). BENZIMIDAZOLE-2-CARBAMIC ACID AS A PRIVILEGED SCAFFOLD FOR ANTIFUNGAL, ANTHELMINTIC AND ANTITUMOR ACTIVITY A REVIEW. 9 indexed citations
4.
Viswanathan, C. L., et al.. (2014). Evaluation of Novel 6-Substituted Benzimidazole-2-Carbamates for Potential Antitumor Activity. Journal of Pharmaceutical Research. 13(4). 102–102. 1 indexed citations
5.
Viswanathan, C. L., et al.. (2011). Efficient Synthesis of 8-Methoxy-3,4-dihydro-2H-1-benzopyran-3-ol. Synthetic Communications. 41(8). 1141–1145.
6.
Viswanathan, C. L., et al.. (2011). Substituted 2-[2-(pyridin-3-yl) phenyl] acetamides and ureas: design, synthesis, and anticonvulsant screening in mice. Medicinal Chemistry Research. 21(8). 1929–1934. 3 indexed citations
7.
Viswanathan, C. L., et al.. (2010). PREDICATION OF BIOLOGICAL ACTIVITY OF ALGAL ANTITUMOR DRUGS USING PASS. 9 indexed citations
8.
Viswanathan, C. L., et al.. (2008). Synthesis and Evaluation of Novel N-Substituted-6-methoxynaphthalene-2-Carboxamides as Potential Chemosensitizing Agents for Cancer. Chemical and Pharmaceutical Bulletin. 56(7). 894–896. 1 indexed citations
9.
Viswanathan, C. L., et al.. (2006). Spherical agglomeration of mefenamic acid and nabumetone to improve micromeritics and solubility: A technical note. AAPS PharmSciTech. 7(2). E122–E125. 26 indexed citations
10.
Khan, Firoz A. Kalam, et al.. (2006). Design, synthesis and in vivo anticonvulsant screening in mice of Novel phenylacetamides. European Journal of Medicinal Chemistry. 41(6). 786–792. 24 indexed citations
11.
Viswanathan, C. L., et al.. (2006). Synthesis and evaluation of uterine relaxant activity for a novel series of substituted p-hydroxyphenylethanolamines. Bioorganic & Medicinal Chemistry. 14(19). 6581–6585. 3 indexed citations
12.
Viswanathan, C. L., et al.. (2006). Design, synthesis and evaluation of naphthalene-2-carboxamides as reversal agents in MDR cancer. Bioorganic & Medicinal Chemistry. 14(17). 6022–6026. 13 indexed citations
13.
Viswanathan, C. L., et al.. (2006). Docking studies and development of novel 5-heteroarylamino-2,4-diamino-8-chloropyrimido-[4,5-b]quinolines as potential antimalarials. Bioorganic & Medicinal Chemistry Letters. 16(10). 2613–2617. 86 indexed citations
14.
Viswanathan, C. L., et al.. (2006). Recent Developments in Antimalarial Drug Discovery. 5(1). 105–122. 38 indexed citations
15.
Khan, Firoz A. Kalam, et al.. (2006). Design, Synthesis and in vivo Anticonvulsant Screening in Mice of Novel Phenylacetamides.. ChemInform. 37(44).
16.
Viswanathan, C. L., et al.. (2005). Design, synthesis and evaluation of racemic 1-(4-hydroxyphenyl)-2-[3-(substituted phenoxy)-2-hydroxy-1-propyl]amino-1-propanol hydrochlorides as novel uterine relaxants. Bioorganic & Medicinal Chemistry Letters. 15(15). 3532–3535. 7 indexed citations
17.
Viswanathan, C. L., et al.. (2005). Novel fluoroquinolones: design, synthesis, and in vivo activity in mice against Mycobacterium tuberculosis H37Rv. Bioorganic & Medicinal Chemistry Letters. 15(7). 1803–1806. 55 indexed citations
18.
Viswanathan, C. L., et al.. (2004). Design, synthesis and evaluation of 5-substituted amino-2,4-diamino-8-chloropyrimido-[4,5-b]quinolines as novel antimalarials. Bioorganic & Medicinal Chemistry Letters. 15(1). 73–76. 72 indexed citations
19.
Viswanathan, C. L., et al.. (1999). Synthesis Of Nicorandil : An Antianginal Agent. Indian Journal of Pharmaceutical Sciences. 61(5). 304. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas D. Avery Breakdown of academic impact, for papers by Karla C. Pais Breakdown of academic impact, for papers by Wei-Chieh Cheng Breakdown of academic impact, for papers by Parameshwar Makam Breakdown of academic impact, for papers by Jozef Csöllei Breakdown of academic impact, for papers by Kishore P. Bhusari Breakdown of academic impact, for papers by Silvia E. Ası́s Breakdown of academic impact, for papers by Garima Verma Breakdown of academic impact, for papers by Lucie Brulíková Breakdown of academic impact, for papers by M. B. Sridhara
Rankless by CCL
2026